CV Sciences (CVSI) Stock Price, News & Analysis

Company Overview

CV Sciences, Inc. is a life sciences company focused on hemp-derived cannabidiol (CBD) and other plant-based wellness products. The company markets its consumer products under the PlusCBD brand, which is designed to provide consumers with a range of CBD formats for everyday wellness.

PlusCBD products have included CBD oil drops, softgels, gummies, capsules, topical creams and balms, and products intended for pets. The company has sold its products through e-commerce channels and retail distribution, primarily serving customers in the United States.

Founded in 2012, CV Sciences is headquartered in San Diego, California. Its business has centered on product development, sourcing and formulation, quality testing, and the distribution of hemp-derived CBD products. The company has also conducted research related to the potential health applications of cannabinoids, although its commercial operations have primarily focused on consumer wellness products.

Key Stats

• Today's Range: $0.0080 to $0.0095
• 50-Day Range: $0.0078 to $0.0195
• 52-Week Range: $0.01 to $0.10
• Volume: 523,559 shs
• Average Volume: 995,545 shs
• Market Capitalization: $2.24 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CV Sciences Stock Analysis - MarketRank™

CV Sciences scored higher than 25% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for CV Sciences.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

CV Sciences has a P/B Ratio of 0.95. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.00% of the float of CV Sciences has been sold short.

Short Interest Ratio / Days to Cover

CV Sciences has a short interest ratio ("days to cover") of 0.01, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in CV Sciences has recently decreased by 82.66%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

CV Sciences does not currently pay a dividend.

Dividend Growth

CV Sciences does not have a long track record of dividend growth.

News and Social Media

• Score: 2.3 / 5
• News Sentiment: 0.66

News Sentiment

CV Sciences has a news sentiment score of 0.66. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for CV Sciences this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.2 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, CV Sciences insiders have not sold or bought any company stock.

Percentage Held by Insiders

6.70% of the stock of CV Sciences is held by insiders.

Percentage Held by Institutions

CV Sciences has minimal institutional ownership at this time.

Company Calendar

• Today: 11/12/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:CVSI
• Previous Symbol: NASDAQ:CVSI
• CIK: 1510964
• Web: www.cvsciences.com
• Phone: (866) 290-2157
• Fax: 619-876-4321
• Employees: 43
• Year Founded: 2016

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$960 thousand
• Net Margins: -15.74%
• Pretax Margin: -15.69%
• Return on Equity: -132.06%
• Return on Assets: -29.50%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.99
• Quick Ratio: 0.18

Sales & Book Value

• Annual Sales: $13.79 million
• Price / Sales: 0.16
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.01 per share
• Price / Book: 0.95

Miscellaneous

• Outstanding Shares: 235,690,000
• Free Float: 219,903,000
• Market Cap: $2.24 million
• Optionable: Not Optionable
• Beta: 0.56